Welcome to our dedicated page for Innovative Medtech SEC filings (Ticker: IMTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AnTix Holdings, Inc., formerly Innovative MedTech, Inc., discloses corporate-status changes and material events for IMTH through Form 8-K filings. Recent records cover the Delaware certificate amendment changing the company’s name, governing-document updates, material definitive agreements, and capital-structure disclosures related to reported corporate actions.
The filings also record the continued IMTH trading symbol at the time of the name-change disclosure, exhibit references, registrant identity information, and board or officer execution records tied to those events.
AnTix Holdings, Inc. (IMTH) reports results for the year ended June 30, 2025, highlighting a major business shift and balance sheet changes. The company posted net income of $1,268,903, compared with a net loss of $7,938,897 the prior year, driven largely by a $3,366,943 gain on the disposition of its SarahCare adult day services subsidiaries and income from discontinued operations.
The core business generated no revenue from continuing operations in 2025, while operating expenses from continuing operations fell to $2,728,979 from $4,003,417, mainly due to lower stock-based compensation and consulting costs. Other income was helped by a $1,140,708 gain on extinguishment of debt, partially offset by a $440,800 impairment on deposits for acquisitions.
The company is exiting adult day services and repositioning as a technology-focused ticketing and media business built around Ticketbash’s artificial intelligence and dynamic pricing software, while maintaining a health and wellness presence through an exclusive Oral Thrush license. Despite reporting net income, AnTix has cumulative losses of $43,292,307, cash of $13,616, a working capital deficit of $1,280,533, and its auditors and management disclose substantial doubt about its ability to continue as a going concern.
Innovative MedTech, Inc. agreed to acquire assets from Grand Concierge LLC d/b/a Ticketbash through an Asset Purchase Agreement originally structured to issue equity and contingent cash/royalty payments but later amended twice. The initial deal would have issued 20,000,000 common shares plus 1,151,500 Series A preferred (convertible into 115,150,000 common) so the sellers would hold 60% of voting rights, and contemplated a $2,000,000 contingent cash payment, royalty tiers (2% up to $15,000,000, 4% between $15,000,000–$25,000,000, and 5% above $25,000,000), plus an additional $1,000,000 investment in development.
Amendments converted the structure twice and ultimately limited the acquisition to a copy and non-exclusive license to Ticketbash source and object code and related materials, with the Purchase Price reduced to the $469,500 already paid by the company. The parties treat the Purchase as closed on October 3, 2025.
AnTix Holdings, Inc., formerly known as Innovative MedTech, Inc., has officially changed its corporate name. On September 19, 2025, the company filed a Certificate of Amendment in Delaware to amend its Amended and Restated Certificate of Incorporation and adopt the new name AnTix Holdings, Inc.
The company’s common stock will continue to trade under the ticker symbol “IMTH” for now. The company states that it intends to file with FINRA to complete the name change process and to change its ticker symbol to a new symbol in the future. Existing stock certificates remain valid and do not need to be exchanged as a result of this name change.